Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formaat:	Artikel
Taal:	Russian
Gepubliceerd in:	«FIRMA «SILICEA» LLC 2004-12-01
Reeks:	Российский кардиологический журнал
Onderwerpen:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Online toegang:	https://russjcardiol.elpub.ru/jour/article/view/2326

Gelijkaardige items

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
door: S. V. Nedogoda, et al.
Gepubliceerd in: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
door: P. P. Tikhonov, et al.
Gepubliceerd in: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
door: S. V. Nedogoda, et al.
Gepubliceerd in: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
door: S. I. Drozdetsky, et al.
Gepubliceerd in: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
door: A. P. Kondrakhin, et al.
Gepubliceerd in: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
door: E. V. Eliseeva, et al.
Gepubliceerd in: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
door: Y. R. Kasherininov, et al.
Gepubliceerd in: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
door: Mehmet Burak Yalçın, et al.
Gepubliceerd in: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
door: Osman Kukula, et al.
Gepubliceerd in: (2024-02-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
door: Nirma D. Perera, et al.
Gepubliceerd in: (2021-07-01)

Main results of the Russian trial «ALTAIR»
door: E. V. Shlyakhto, et al.
Gepubliceerd in: (2006-02-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
door: Monique L Parkin, et al.
Gepubliceerd in: (2016-11-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
door: N. N. Nikitina, et al.
Gepubliceerd in: (2015-12-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
door: V. Estato, et al.
Gepubliceerd in: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
door: L. A. Khaisheva, et al.
Gepubliceerd in: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
door: V. I. Makolkin
Gepubliceerd in: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
door: András Érszegi, et al.
Gepubliceerd in: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
door: L. I. Markova, et al.
Gepubliceerd in: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
door: V. A. Nevzorova, et al.
Gepubliceerd in: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
door: I. E. Chazova, et al.
Gepubliceerd in: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
door: I. N. Medvedev, et al.
Gepubliceerd in: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
door: I. N. Medvedev, et al.
Gepubliceerd in: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
door: I. N. Medvedev, et al.
Gepubliceerd in: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
door: I. N. Medvedev, et al.
Gepubliceerd in: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
door: A. P. Vasilyev, et al.
Gepubliceerd in: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
door: A. N. Britov, et al.
Gepubliceerd in: (2006-06-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
door: E. G. Ivanova, et al.
Gepubliceerd in: (2023-04-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
door: N. J. Gromnazky, et al.
Gepubliceerd in: (2003-12-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
door: G. N. Gorokhovskaya, et al.
Gepubliceerd in: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
door: L. I. Abasova, et al.
Gepubliceerd in: (2011-08-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
door: M. M. Beraya, et al.
Gepubliceerd in: (2007-02-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
door: E. G. Ivanova, et al.
Gepubliceerd in: (2022-07-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
door: A S Ryazanov, et al.
Gepubliceerd in: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
door: M. M. Beraya, et al.
Gepubliceerd in: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
door: E. V. Tishina, et al.
Gepubliceerd in: (2011-06-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
door: Michał Łata, et al.
Gepubliceerd in: (2025-01-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
door: V. V. Trusov, et al.
Gepubliceerd in: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
door: Roman A. Yaskevich, et al.
Gepubliceerd in: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
door: Roman A. Yaskevich, et al.
Gepubliceerd in: (2022-06-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
door: I. S. Dzherieva, et al.
Gepubliceerd in: (2015-12-01)